Comparison of Innovator vs. Biosimilar Ranibizumab in Treating Diabetic Macular Edema: A Multicenter Retrospective Study.
Debdulal ChakrabortySabyasachi SenguptaSoumen MondalSubhendu BoralArnab DasTushar Kanti SinhaRanabir BhattacharyaRitobroto MaitraPublished in: Ophthalmology and therapy (2022)
Biosimilar RBZ is similar to innovator RBZ in improving vision and reducing CMT in eyes with DME in the short term.